Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Co
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: QTTB) | Delayed: 8.65 -0.15 (1.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.80 | 52 Week High | $ | |||
| Open | $8.80 | 52 Week Low | $ | |||
| Day High | $8.84 | P/E | N/A | |||
| Day Low | $8.30 | EPS | $ | |||
| Volume | 404,045 | |||||
